It is far better to decide what your agenda ought to be the night before and make that the first thing you focus on at work, without interruption, for up to 90 minutes.
However, in this report we computed the data of only 57 patients since they represent the ones who were injected regularly every 3 months without interruption until up to cycle 7 at least.
Data were collected from the starting date of chemotherapy until interruption, for up to seven drugs in each cycle of chemotherapy (corresponding to a theoretic 21-days period), with the daily dose and the number of days of assumption recorded.
Dose interruption and up to two dose reductions of sorafenib (to 200 mg bid and 200 mg qd) were undertaken for sorafenib-associated grade 3 to 4 hematologic and grade 3 nonhematologic toxicities.
While AI-induced arthralgias were reported as mild to moderate in severity and did not result in significant discontinuation of medication in the large trials [ 58, 59], in more recent analyses, severe AI-induced arthralgias resulted in therapy interruption in up to 20% of patients [ 52, 55, 60].
In American prime-time television, advertising interruptions added up to 18 minutes an hour last year, up from 13 minutes an hour in 1992, according to Parks Associates.
Sorafenib was administered at 50% of the planned dose if any severe adverse events related to the study drug occurred, and in frail patients.[10] In sorafenib group, treatment interruptions and up to two dose reductions (first to 400 mg once daily and then to 400 mg every 2 days) were done in case of drug-related adverse effects.
Other studies revealed that interruptions affected up to 94%% [ 2– 4] of primary care consultations.
Treatment interruptions and up to two dose reductions (first to 400 mg once daily and then to 400 mg every 2 days) were permitted for drug-related adverse effects (National Cancer Institute-Common Terminology Criteria (NCI-CTC, version 3)).
The CPCRA 064 study examined the effect of structured treatment interruption (STI) of up to 4 months followed by salvage treatment in patients failing therapy with multi-drug resistant HIV.
